Atomwise pursues 15 collaborations for COVID-19 treatments
May 22, 2020 -- Small molecule drug discovery company Atomwise has announced it is collaborating with 15 institutions to develop broad-spectrum therapies for coronaviruses, including the novel coronavirus responsible for COVID-19.
Cargill, Eagle Genomics partner on microbiome research
May 20, 2020 -- Eagle Genomics and Cargill Health Technologies have signed a multiyear platform agreement to accelerate microbiome and life sciences research and development.
Roche becomes founding partner of biotech accelerator
May 15, 2020 -- Roche has become a founding partner in the second phase of development of BaseLaunch, a Basel, Switzerland-based incubator and accelerator that helps scientists and entrepreneurs launch biotech companies.
Yumab identifies COVID-19 antibody therapy
May 13, 2020 -- German biotechnology company Yumab said it has identified a promising candidate for COVID-19 antibody therapy.
BD revenues edge up for 2nd quarter
May 7, 2020 -- Becton Dickinson (BD) saw its revenues grow slightly for the second quarter, but the company withdrew its previously issued guidance due to fallout from the COVID-19 pandemic.
Recursion launches dataset for COVID-19 drug discovery
April 27, 2020 -- Digital biology company Recursion has released an open-source RxRx19 dataset, the first human cellular morphological dataset of SARS-CoV-2, it said.
Selvita, Ardigen collaborate on HiScAI
April 27, 2020 -- Selvita and Ardigen are partnering to create the High-Content Screening Artificial Intelligence (HiScAI) platform, which is designed to accelerate drug discovery with the use of artificial intelligence.
Medable launches COVID-19 research collaboration
April 20, 2020 -- Medable has launched a research collaboration with five other organizations to develop diagnostics and treatment for COVID-19.
Loop Genomics debuts SARS-CoV-2 sequencing service
April 17, 2020 -- Loop Genomics has launched a new service for long-read sequencing of long amplicons of SARS-CoV-2, the virus that causes COVID-19.
Scripps Research expands drug repurposing efforts for COVID-19
April 16, 2020 -- Scripps Research has pivoted its drug repurposing collection ReFRAME to find antiviral compounds effective against the novel coronavirus.
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
General Discussion
Topic Replies / Views Last Update
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 29 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 12 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter